Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses
- 1 January 1983
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 24 (3) , 353-356
- https://doi.org/10.1007/bf00610054
Abstract
The plasma concentration curves and urinary excretion of oxmetidine after administration of single i.v. (100 mg) and oral (200 mg) doses have been studied in 11 patients with peptic ulcer disease. The mean bioavailability of the drug was 70% (range 53–91%). After intravenous administration, the mean plasmat 1/2β was 3.0 h, the mean apparent volume of distribution 0.7 l/kg, the mean total plasma clearance 12.3 l/h and the mean plasma renal clearance was 0.7 l/h. Following intravenous and oral administration an average of 6% and 3%, respectively, of unchanged drug was found in the urine. The plasma concentration curve after oral administration in most patients exhibited two maxima, with peak concentrations appearing between 45 and 210 min after dosing.This publication has 5 references indexed in Scilit:
- Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist.Gut, 1982
- Pharmacokinetics of Cimetidine after Single Doses and during Continuous TreatmentClinical Pharmacokinetics, 1981
- Prolactin responses to histamine H2 receptor antagonistsActa Endocrinologica, 1980
- The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine‐studies in patients with peptic ulcer disease.British Journal of Clinical Pharmacology, 1979